Affiliation
Department of Molecular Medicine, Royal College of Surgeons in Ireland, Education, and Research Centre, Beaumont Hospital, Dublin 9, Ireland. ruthdooley@rcsi.ieIssue Date
2012-02-01T10:01:25ZMeSH
11-beta-Hydroxysteroid Dehydrogenase Type 2Aldosterone/*physiology
Animals
Blood Vessels/physiology
Brain/drug effects/physiopathology
Cardiovascular Diseases/physiopathology
Cell Differentiation/drug effects
Cell Proliferation/drug effects
Cell Survival/drug effects
Humans
Kidney/drug effects/physiopathology
Kidney Diseases/physiopathology
MAP Kinase Signaling System/physiology
Myocytes, Cardiac/physiology
Nephrons/drug effects/growth & development
Receptors, Aldosterone/physiology
Receptors, Glucocorticoid/physiology
Receptors, Mineralocorticoid/drug effects/*physiology
Renin-Angiotensin System/physiology
Metadata
Show full item recordCitation
Front Biosci. 2011 Jan 1;16:440-57.Journal
Frontiers in bioscience : a journal and virtual libraryPubMed ID
21196180Abstract
The steroid hormone aldosterone is synthesized from cholesterol, mainly in the zona glomerulosa of the adrenal cortex. Aldosterone exerts its effects in the epithelial tissues of the kidney and colon and in non-epithelial tissues such as the brain and cardiovasculature. The genomic response to aldosterone involves dimerization of the mineralocorticoid receptor (MR), dissociation of heat shock proteins from MR, translocation of the aldosterone-MR complex to the nucleus and the concomitant regulation of gene expression. Rapid responses to aldosterone occur within seconds to minutes, do not involve transcription or translation and can modulate directly or indirectly the later genomic responses. Aside from the well-known effects of aldosterone on the regulation of sodium and water homeostasis, aldosterone can also produce deleterious structural changes in tissues by inducing hypertrophy and the dysregulation of proliferation and apoptosis, leading to fibrosis and tissue remodelling. Here we discuss the involvement of aldosterone-mediated rapid signalling cascades in the development of disease states such as chronic kidney disease and heart failure, and the antagonists that can inhibit these pathophysiological responses.Language
engISSN
1093-4715 (Electronic)1093-4715 (Linking)